Burgdorf – Company has strengthened and enhanced its market position in the fast-growing US needle business.
Lees meer... Ypsomed wins new supply contract for pen needles
Burgdorf – Ypsomed investing in Switzerland.
Lees meer... Semiannual results: report and press release
Burgdorf – At the general meeting of 27 June 2012 Ypsomed shareholders approved the growth strategy.
Lees meer... Ypsomed examines investment options
Burgdorf – Ypsomed has recruited two experienced diabetes care executives to boost its diabetes treatment product franchise.
Lees meer... Ypsomed recruits expertise to grow diabetes care business
Burgdorf – In the past 2011/12 business year, the Ypsomed Group increased net profit by 55.5% to CHF 8.5 million, which was positively affected by the sale of financial assets.
Lees meer... Ypsomed 2011/12 business year